Literature DB >> 28684948

Methylphenidate: Brain Gain for the Epilepsy Drain.

Jong Woo Lee.   

Abstract

Entities:  

Year:  2017        PMID： 28684948      PMCID： PMC5486423          DOI： 10.5698/1535-7511.17.3.157

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  12 in total

Review 1.  Cognition in the early stages of adult epilepsy.

Authors:  Juri-Alexander Witt; Christoph Helmstaedter
Journal:  Seizure       Date:  2015-02-07       Impact factor: 3.184

2.  Influence of fatigue, depression, and demographic, socioeconomic, and clinical variables on quality of life of patients with epilepsy.

Authors:  Vesile Senol; Ferhan Soyuer; Fehim Arman; Ahmet Oztürk
Journal:  Epilepsy Behav       Date:  2006-11-09       Impact factor: 2.937

3.  Cognitive phenotypes in temporal lobe epilepsy.

Authors:  Bruce Hermann; Michael Seidenberg; Eun-Jeong Lee; Fong Chan; Paul Rutecki
Journal:  J Int Neuropsychol Soc       Date:  2007-01       Impact factor: 2.892

Review 4.  Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.

Authors:  Dimitris Repantis; Peter Schlattmann; Oona Laisney; Isabella Heuser
Journal:  Pharmacol Res       Date:  2010-04-21       Impact factor: 7.658

Review 5.  Treatment of Cognitive Deficits in Epilepsy.

Authors:  Beth A Leeman-Markowski; Steven C Schachter
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

6.  A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy.

Authors:  Marla J Hamberger; Christina A Palmese; Nikolaos Scarmeas; David Weintraub; Hyunmi Choi; Lawrence J Hirsch
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

Review 7.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

8.  Should cognition be screened in new-onset epilepsies? A study in 247 untreated patients.

Authors:  Juri-Alexander Witt; Christoph Helmstaedter
Journal:  J Neurol       Date:  2012-05-12       Impact factor: 4.849

9.  Methylphenidate, cognition, and epilepsy: A double-blind, placebo-controlled, single-dose study.

Authors:  Jesse Adams; Valerie Alipio-Jocson; Katherine Inoyama; Victoria Bartlett; Saira Sandhu; Jemima Oso; John J Barry; David W Loring; Kimford Meador
Journal:  Neurology       Date:  2016-12-28       Impact factor: 9.910

Review 10.  Ostracising caffeine from the pharmacological arsenal for attention-deficit hyperactivity disorder--was this a correct decision? A literature review.

Authors:  Konstantinos Ioannidis; Samuel R Chamberlain; Ulrich Müller
Journal:  J Psychopharmacol       Date:  2014-07-01       Impact factor: 4.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.